METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

A practical reversed-phase high-performance liquid chromatography (HPLC) method was developed for 4-chloro-N-furfuryl-5-sulphamoylanthranilic acid (furosemide) determination in plasma. The plasma samples spiked with the drug in presence of propranolol hydrochloride as internal standard, were purified using a liquid - liquid extraction technique. The drugs were separated through a Kromasil 100-5C18 column with a mobile phase composed of acetonitrile and 0.02 M potassium dihydrogen phosphate (34 : 66 v/v) adjusted to pH 3.0 and quantified by fluorescence detection (excitation at 268 nm, emission at 410 nm). The calibration curve was linear ranging between 0.005 and 1.500 mg/mL. The detection limit was 0.001mg/mL and the quantification limit 0.003 mg/mL in plasma. The furosemide recovery from 1mL of plasma was between 99.8 and 101.6 %, with a variation coefficient not higher than 4,85 %. The method is sensitive enough for use in bioavailability and bioequivalence studies after oral administration of 40 mg (a tablet) of furosemide

Saved in:
Bibliographic Details
Main Authors: GOMEZ G,CAROLINA, PLESSING R,CARLOS von, GODOY M,C. GLORIA, REINBACH H,ROLANDO, GODOY R,RICARDO
Format: Digital revista
Language:English
Published: Sociedad Chilena de Química 2005
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072005000200008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0717-97072005000200008
record_format ojs
spelling oai:scielo:S0717-970720050002000082005-07-19METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTIONGOMEZ G,CAROLINAPLESSING R,CARLOS vonGODOY M,C. GLORIAREINBACH H,ROLANDOGODOY R,RICARDO 4-chloro-N-furfuryl-5-sulphamoylanthranilic acid urosemide liquid-liquid extraction from plasma HPLC with fluorescence detection validation A practical reversed-phase high-performance liquid chromatography (HPLC) method was developed for 4-chloro-N-furfuryl-5-sulphamoylanthranilic acid (furosemide) determination in plasma. The plasma samples spiked with the drug in presence of propranolol hydrochloride as internal standard, were purified using a liquid - liquid extraction technique. The drugs were separated through a Kromasil 100-5C18 column with a mobile phase composed of acetonitrile and 0.02 M potassium dihydrogen phosphate (34 : 66 v/v) adjusted to pH 3.0 and quantified by fluorescence detection (excitation at 268 nm, emission at 410 nm). The calibration curve was linear ranging between 0.005 and 1.500 mg/mL. The detection limit was 0.001mg/mL and the quantification limit 0.003 mg/mL in plasma. The furosemide recovery from 1mL of plasma was between 99.8 and 101.6 %, with a variation coefficient not higher than 4,85 %. The method is sensitive enough for use in bioavailability and bioequivalence studies after oral administration of 40 mg (a tablet) of furosemideinfo:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.50 n.2 20052005-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072005000200008en10.4067/S0717-97072005000200008
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author GOMEZ G,CAROLINA
PLESSING R,CARLOS von
GODOY M,C. GLORIA
REINBACH H,ROLANDO
GODOY R,RICARDO
spellingShingle GOMEZ G,CAROLINA
PLESSING R,CARLOS von
GODOY M,C. GLORIA
REINBACH H,ROLANDO
GODOY R,RICARDO
METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
author_facet GOMEZ G,CAROLINA
PLESSING R,CARLOS von
GODOY M,C. GLORIA
REINBACH H,ROLANDO
GODOY R,RICARDO
author_sort GOMEZ G,CAROLINA
title METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
title_short METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
title_full METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
title_fullStr METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
title_full_unstemmed METHOD VALIDATION FOR THE DETERMINATION OF FUROSEMIDE IN PLASMA BY LIQUID- LIQUID EXTRACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
title_sort method validation for the determination of furosemide in plasma by liquid- liquid extraction and high-performance liquid chromatography with fluorescence detection
description A practical reversed-phase high-performance liquid chromatography (HPLC) method was developed for 4-chloro-N-furfuryl-5-sulphamoylanthranilic acid (furosemide) determination in plasma. The plasma samples spiked with the drug in presence of propranolol hydrochloride as internal standard, were purified using a liquid - liquid extraction technique. The drugs were separated through a Kromasil 100-5C18 column with a mobile phase composed of acetonitrile and 0.02 M potassium dihydrogen phosphate (34 : 66 v/v) adjusted to pH 3.0 and quantified by fluorescence detection (excitation at 268 nm, emission at 410 nm). The calibration curve was linear ranging between 0.005 and 1.500 mg/mL. The detection limit was 0.001mg/mL and the quantification limit 0.003 mg/mL in plasma. The furosemide recovery from 1mL of plasma was between 99.8 and 101.6 %, with a variation coefficient not higher than 4,85 %. The method is sensitive enough for use in bioavailability and bioequivalence studies after oral administration of 40 mg (a tablet) of furosemide
publisher Sociedad Chilena de Química
publishDate 2005
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072005000200008
work_keys_str_mv AT gomezgcarolina methodvalidationforthedeterminationoffurosemideinplasmabyliquidliquidextractionandhighperformanceliquidchromatographywithfluorescencedetection
AT plessingrcarlosvon methodvalidationforthedeterminationoffurosemideinplasmabyliquidliquidextractionandhighperformanceliquidchromatographywithfluorescencedetection
AT godoymcgloria methodvalidationforthedeterminationoffurosemideinplasmabyliquidliquidextractionandhighperformanceliquidchromatographywithfluorescencedetection
AT reinbachhrolando methodvalidationforthedeterminationoffurosemideinplasmabyliquidliquidextractionandhighperformanceliquidchromatographywithfluorescencedetection
AT godoyrricardo methodvalidationforthedeterminationoffurosemideinplasmabyliquidliquidextractionandhighperformanceliquidchromatographywithfluorescencedetection
_version_ 1755993392042475520